The use of DREADDs (designer receptors exclusively activated by designer receptors) in transgenic mouse behavioral models

Daniela Cassataro, Lucas L. Sjulson

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) are increasingly used to manipulate activity in specific neuronal populations in the brains of awake, behaving mice. Here we review the pros and cons of DREADDs relative to other genetically encoded neuromodulation technologies and describe in detail methods for using DREADDs with transgenic mouse behavioral models. This approach can not only provide insight into the role of specific neural circuits in behavior but also identify potential neuromodulation targets for the treatment of neuropsychiatric disorders.

Original languageEnglish (US)
Title of host publicationDesigner Receptors Exclusively Activated by Designer Drugs
PublisherSpringer New York
Pages95-108
Number of pages14
ISBN (Electronic)9781493929443
ISBN (Print)9781493929436
DOIs
StatePublished - Sep 4 2015
Externally publishedYes

Fingerprint

Designer Drugs
Transgenic Mice
Technology
Brain
Population

Keywords

  • Addiction
  • CNO
  • DREADDs
  • Mouse behavior
  • Reverse pharmacogenetics
  • Transgenic mice

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

The use of DREADDs (designer receptors exclusively activated by designer receptors) in transgenic mouse behavioral models. / Cassataro, Daniela; Sjulson, Lucas L.

Designer Receptors Exclusively Activated by Designer Drugs. Springer New York, 2015. p. 95-108.

Research output: Chapter in Book/Report/Conference proceedingChapter

Cassataro, Daniela ; Sjulson, Lucas L. / The use of DREADDs (designer receptors exclusively activated by designer receptors) in transgenic mouse behavioral models. Designer Receptors Exclusively Activated by Designer Drugs. Springer New York, 2015. pp. 95-108
@inbook{155eeb6865bb49d4b21ee6a4371f2aef,
title = "The use of DREADDs (designer receptors exclusively activated by designer receptors) in transgenic mouse behavioral models",
abstract = "Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) are increasingly used to manipulate activity in specific neuronal populations in the brains of awake, behaving mice. Here we review the pros and cons of DREADDs relative to other genetically encoded neuromodulation technologies and describe in detail methods for using DREADDs with transgenic mouse behavioral models. This approach can not only provide insight into the role of specific neural circuits in behavior but also identify potential neuromodulation targets for the treatment of neuropsychiatric disorders.",
keywords = "Addiction, CNO, DREADDs, Mouse behavior, Reverse pharmacogenetics, Transgenic mice",
author = "Daniela Cassataro and Sjulson, {Lucas L.}",
year = "2015",
month = "9",
day = "4",
doi = "10.1007/978-1-4939-2944-3_6",
language = "English (US)",
isbn = "9781493929436",
pages = "95--108",
booktitle = "Designer Receptors Exclusively Activated by Designer Drugs",
publisher = "Springer New York",

}

TY - CHAP

T1 - The use of DREADDs (designer receptors exclusively activated by designer receptors) in transgenic mouse behavioral models

AU - Cassataro, Daniela

AU - Sjulson, Lucas L.

PY - 2015/9/4

Y1 - 2015/9/4

N2 - Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) are increasingly used to manipulate activity in specific neuronal populations in the brains of awake, behaving mice. Here we review the pros and cons of DREADDs relative to other genetically encoded neuromodulation technologies and describe in detail methods for using DREADDs with transgenic mouse behavioral models. This approach can not only provide insight into the role of specific neural circuits in behavior but also identify potential neuromodulation targets for the treatment of neuropsychiatric disorders.

AB - Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) are increasingly used to manipulate activity in specific neuronal populations in the brains of awake, behaving mice. Here we review the pros and cons of DREADDs relative to other genetically encoded neuromodulation technologies and describe in detail methods for using DREADDs with transgenic mouse behavioral models. This approach can not only provide insight into the role of specific neural circuits in behavior but also identify potential neuromodulation targets for the treatment of neuropsychiatric disorders.

KW - Addiction

KW - CNO

KW - DREADDs

KW - Mouse behavior

KW - Reverse pharmacogenetics

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=84955129503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955129503&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-2944-3_6

DO - 10.1007/978-1-4939-2944-3_6

M3 - Chapter

AN - SCOPUS:84955129503

SN - 9781493929436

SP - 95

EP - 108

BT - Designer Receptors Exclusively Activated by Designer Drugs

PB - Springer New York

ER -